Why the study?
CSD is a therapeutic option for refractory VT, but long-term outcomes needed evaluation, particularly when performed ahead of catheter ablation.
Does cardiac sympathetic denervation reduce ICD shocks in patients with structural heart disease and refractory ventricular tachycardia?
Population
65 patients with SHD and refractory VT and/or VT storm
Comparison
Cardiac sympathetic denervation
Design
Retrospective cohort study
Follow-up
Mean 27 ± 24 months
Authors
Loading...
May support CSD before CA in refractory VT; leaves open confirmation via prospective trials.
Does cardiac sympathetic denervation reduce ICD shocks in patients with structural heart disease and refractory ventricular tachycardia?
Cardiac sympathetic denervation significantly reduces the burden of ICD shocks in patients with structural heart disease and refractory ventricular tachycardia.
Barwad et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: